RecruitingNot ApplicableNCT07818889

Study to Refine the Effectiveness of New Generation Therapies for Suicide

STRENGTHENS: Study To Refine the Effectiveness of New Generation Therapies for Suicide

Sponsor

Ohio State University

Enrollment

50 participants

Start Date

Apr 29, 2026

Study Type

INTERVENTIONAL

Conditions

Treatment Response Suicide Attempt Suicide Risk

Summary

The purpose of this research study is to improve the effectiveness of a well-established therapy for suicidal thoughts and behaviors called Brief Cognitive Behavioral Therapy (BCBT) for Suicide Prevention.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Brief Cognitive Behavioral Therapy for people with suicide attempt, suicide risk, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBrief Cognitive Behavioral Therapy

In this study, BCBT skills will be introduced in various randomly determined sequence. During the first stage, around half of participants will complete reasons for living in session 2, physiological regulation in session 3, and sleep in session 4. The other half of participants will complete these components in the reverse order: sleep in session 2, physiological regulation in session 3, and reasons for living in session 4. Treatment non-responders will continue attending BCBT sessions during Stage 2 following their 4 completed sessions in Stage 1, up to a maximum of 6 additional sessions (i.e., 10 therapy sessions total across both stages). The specific sequence of the BCBT skills used in Stage 2 will be randomly assigned.